Healthcare economists note that the current pricing structure creates access barriers for patients seeking these medications, particularly those without comprehensive drug coverage
Medication-Specific Adjustments Guidelines from the FDA and KDIGO-ADA 2022 indicate that liraglutide (Saxenda), semaglutide (Wegovy, Ozempic), and tirzepatide (Zepbound, Mounjaro) do not require dose adjustments for CKD patients
GLP-1 and GIP can decelerate gastric emptying, thus moderating the rate of nutrient absorption and aiding glycemic control
Furthermore, drug-caused hypoglycemia can lead to temporary visual disturbances, including floaters, due to changes in retinal blood flow or temporary retinal ischemia
By contrast, ECL2 and the top end of TM5 were more mobile in the GLP-1RTT-OAD2G s complex